Titan Pharmaceuticals, Inc is a biotechnology business based in the US. Titan Pharmaceuticals shares (TTNP) are listed on the NASDAQ and all prices are listed in US Dollars. Titan Pharmaceuticals employs 12 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Titan Pharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – TTNP – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Titan Pharmaceuticals stock price (NASDAQ: TTNP)Use our graph to track the performance of TTNP stocks over time.
Titan Pharmaceuticals shares at a glance
|Latest market close||$2.45|
|52-week range||$2.15 - $9.53|
|50-day moving average||$2.45|
|200-day moving average||$2.81|
|Wall St. target price||$7.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.93|
Buy Titan Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Titan Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Titan Pharmaceuticals price performance over time
|1 week (2021-07-20)||N/A|
|1 month (2021-07-01)||-4.67%|
|3 months (2021-04-30)||-2.78%|
|6 months (2021-01-27)||N/A|
|1 year (2020-07-27)||N/A|
|2 years (2019-07-27)||N/A|
|3 years (2018-07-27)||N/A|
|5 years (2016-07-27)||N/A|
Titan Pharmaceuticals financials
|Revenue TTM||$4.4 million|
|Gross profit TTM||$-1,550,000|
|Return on assets TTM||-36.96%|
|Return on equity TTM||-88.03%|
|Market capitalisation||$23 million|
TTM: trailing 12 months
Shorting Titan Pharmaceuticals shares
There are currently 403,685 Titan Pharmaceuticals shares held short by investors – that's known as Titan Pharmaceuticals's "short interest". This figure is 4.4% down from 422,416 last month.
There are a few different ways that this level of interest in shorting Titan Pharmaceuticals shares can be evaluated.
Titan Pharmaceuticals's "short interest ratio" (SIR)
Titan Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Titan Pharmaceuticals shares currently shorted divided by the average quantity of Titan Pharmaceuticals shares traded daily (recently around 144689.96415771). Titan Pharmaceuticals's SIR currently stands at 2.79. In other words for every 100,000 Titan Pharmaceuticals shares traded daily on the market, roughly 2790 shares are currently held short.
However Titan Pharmaceuticals's short interest can also be evaluated against the total number of Titan Pharmaceuticals shares, or, against the total number of tradable Titan Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Titan Pharmaceuticals's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Titan Pharmaceuticals shares in existence, roughly 40 shares are currently held short) or 0.0475% of the tradable shares (for every 100,000 tradable Titan Pharmaceuticals shares, roughly 48 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Titan Pharmaceuticals.
Find out more about how you can short Titan Pharmaceuticals stock.
Titan Pharmaceuticals share dividends
We're not expecting Titan Pharmaceuticals to pay a dividend over the next 12 months.
Have Titan Pharmaceuticals's shares ever split?
Titan Pharmaceuticals's shares were split on a 1:30 basis on 30 November 2020. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Titan Pharmaceuticals shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Titan Pharmaceuticals shares which in turn could have impacted Titan Pharmaceuticals's share price.
Titan Pharmaceuticals share price volatility
Over the last 12 months, Titan Pharmaceuticals's shares have ranged in value from as little as $2.15 up to $9.531. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Titan Pharmaceuticals's is 0.7797. This would suggest that Titan Pharmaceuticals's shares are less volatile than average (for this exchange).
Titan Pharmaceuticals overview
Titan Pharmaceuticals, Inc. , a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program, TP-2021 for use in combination with ProNeura technology for treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including non-clinical evaluation of the ProNeura platform in malaria prophylaxis. Titan Pharmaceuticals, Inc. was incorporated in 1992 and is based in South San Francisco, California.
Stocks similar to Titan Pharmaceuticals
Titan Pharmaceuticals in the news
Frequently asked questionsWhat percentage of Titan Pharmaceuticals is owned by insiders or institutions?
Currently 6.973% of Titan Pharmaceuticals shares are held by insiders and 17.186% by institutions. How many people work for Titan Pharmaceuticals?
Latest data suggests 12 work at Titan Pharmaceuticals. When does the fiscal year end for Titan Pharmaceuticals?
Titan Pharmaceuticals's fiscal year ends in December. Where is Titan Pharmaceuticals based?
Titan Pharmaceuticals's address is: 400 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 What is Titan Pharmaceuticals's ISIN number?
Titan Pharmaceuticals's international securities identification number is: US8883145075 What is Titan Pharmaceuticals's CUSIP number?
Titan Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 888314101
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert